- Treatment of relapsing-remitting multiple sclerosis2008 | First Faculty of Medicine
- Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase2020 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison2014 | First Faculty of Medicine
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study2012 | Second Faculty of Medicine
- Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis2023 | First Faculty of Medicine, Third Faculty of Medicine
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study2010 | First Faculty of Medicine
- Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry2022 | Second Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study2014 | First Faculty of Medicine
- Interferon beta-1a vs. glatiramer acetate: changes of innate immunity in a group of women with multiple sclerosis2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study2012 | First Faculty of Medicine
- ECTRIMS/ACTRIMS 2017 - News in research and treatment of Multiple Sclerosis2017 | Publication without faculty affiliation
